Literature DB >> 9014623

Comparison of patient-controlled sedation with either methohexitone or propofol.

S K Hamid1, N McCann, L McArdle, A J Asbury.   

Abstract

We studied 42 patients undergoing oral surgery under local anaesthesia with i.v. sedation, allocated randomly to receive either methohexitone (group M) or propofol (group P) for patient-controlled sedation (PCS). Group M patients self-administered 2.5-mg (0.5 ml) bolus doses of methohexitone and group P, 5-mg (0.5 ml) doses of propofol, without a lockout. The 0.5-ml bolus dose was delivered over 7.2 s for both drugs. The procedure was completed satisfactorily in all patients. Patients in both groups achieved their desired levels of sedation. No patient lost verbal contact. Group M patients had higher heart rates during the procedure. The lowest SpO2 values recorded were 92% and 95% for group P and group M, respectively. Immediately after operation patients in group M reported that they felt more sleepy than those in group P (P < 0.01) but there were no differences at subsequent times. The results of the psychomotor tests were comparable for the two groups after operation, except for the "posting box task" at 15 min after operation when the mean decrement (compared with preoperative performance) was -3% for group P and -13% for group M (P < 0.05). More patients in group P complained of pain in their hand. We conclude that methohexitone is a suitable alternative drug to propofol for PCS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014623     DOI: 10.1093/bja/77.6.727

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.

Authors:  D M Steinbacher
Journal:  Anesth Prog       Date:  2001

2.  Patient-controlled sedation.

Authors:  C Rodrigo
Journal:  Anesth Prog       Date:  1998

Review 3.  Monitored anaesthesia care in the elderly: guidelines and recommendations.

Authors:  Margaret Ekstein; Doron Gavish; Tiberiu Ezri; Avi A Weinbroum
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.